Registry Study on Control Nocturnal Hypertension to Reach the Target (CONTROL-NHT)

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Ambulatory blood pressure monitoring (ABPM) is a major innovation in the history of hypertension diagnosis. In clinical practice, the most well established indication for using ABPM is to identify patients who have high BP readings in the office but normal readings during usual daily activities outside of this setting or vice versa, and to identify varying 24-h BP profiles. However, in recent years, there has been increasing interest in BP values during sleep, and nocturnal BP is now recognized to be superior to daytime BP in predicting fatal and nonfatal cardiovascular events (stroke, myocardial infarction, and cardiovascular death), especially in medicated patients. The current direction in the management of hypertension is toward earlier and lower BP control for 24 hours, including the nocturnal and morning periods. Therefore, it may be of great significance to pay attention to the management of nocturnal blood pressure so as to reduce the increased cardiovascular risks. Information of nocturnal hypertensive patients defined by ABPM was prospectively registered nationwide, and then to investigate whether there was difference in cardiovascular prognosis according to the control of ambulatory nocturnal blood pressure.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 79
Healthy Volunteers: f
View:

• Age 50-79 years old

• Clinical diagnosed hypertension with the use of antihypertensive drugs

• Nocturnal hypertension ( nocturnal systolic blood pressure ≥ 130 mmHg and/or nocturnal diastolic blood pressure ≥ 80 mmHg)

• A 24-hour ambulatory blood pressure monitoring was performed with validated equipment.

• Willing to provide information about disease history and blood biochemical test data within 6 months.

• Sign the informed consent

Locations
Other Locations
China
Ruijin Hospital
RECRUITING
Shanghai
Contact Information
Primary
Yan Li, MD,PhD
liyanshcn@163.com
0086-021-64370045
Time Frame
Start Date: 2019-12-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 4500
Treatments
Nocturnal controlled hypertension
Nocturnal blood pressure was controlled under 120/70 mmHg after aggressive anti-hypertensive therapy.
Nocturnal uncontrolled hypertension
Nocturnal blood pressure was still over 120/70 mmHg after aggressive anti-hypertensive therapy.
Authors
Related Therapeutic Areas
Sponsors
Leads: Shanghai Institute of Hypertension

This content was sourced from clinicaltrials.gov

Similar Clinical Trials